高级检索
当前位置: 首页 > 详情页

Comparison of the effect of postoperative radiotherapy with surgery alone for esophagus squamous cell carcinoma patients A meta-analysis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China [2]Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Anim Physiol Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China
出处:
ISSN:

关键词: meta-analysis postoperative radiotherapy surgery

摘要:
Background: This meta-analysis was conducted to evaluate the effect of postoperative radiotherapy for patients having esophagus squamous cell carcinoma after radical surgery. Methods: A comprehensive research was performed in Pubmed, Embase and Cochrane Library electronic databases from inception until December 10, 2017. We collected all published full articles about comparison of surgery plus postoperative radiotherapy with surgery alone. Results: Four randomized-controlled trials (RCTs) with 1050 participants and 8 non-randomized-controlled trials with 3248 participants were included and evaluated separately. The risk ratio rate and its 95% confidence interval (CI) were calculated. Both RCTs and non-randomized-controlled trials (NRCTs) groups showed a significant increase in 3-year overall survival (OS) rate (RRRCT=0.89, 95% CI: 0.80-0.99; RRNRCT=0.82, 95% CI: 0.76-0.88) and decrease locoregional recurrence rate (RRRCT=0.53, 95% CI: 0.43-0.66; RRNRCT=0.47, 95% CI: 0.32-0.69) after postoperative radiotherapy compared with surgery alone. The 5-year OS rate in the group of NRCTs was markedly enhanced (RR=0.87, 95% CI: 0.82-0.92), while that of the RCTs group was not enhanced in a significant way (RR=0.84, 95% CI: 0.70-1.02). Subgroup analysis based on pathological lymph node status revealed that postoperative radiotherapy could improve OS regardless of pathological lymph node status (pathological lymph node positive patients: RR5-year os-RCT=0.81, 95% CI: 0.70-0.93; RR5-year os-NRCT=0.87, 95% CI: 0.80-0.94; Pathological lymph node negative patients: RR3-year os-RCT=0.76, 95% CI: 0.59-0.96; RR3-year os-NRCT=0.52, 95% CI: 0.30-0.89). No effect on distant recurrence rate was detected. Adverse effects induced by postoperative radiotherapy were comparatively modest and tolerable. Conclusion: Polled results yielded that postoperative radiotherapy was promising in improving OS and reducing the locoregional recurrence rate. More large-scale up-to-date RCTs are needed to further validate the use of postoperative radiotherapy in modern practice.

基金:

基金编号: H2014206330 H2017206170 QN2015256

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12 Hlth Rd, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Radiation Oncology, The Fourth Hospital Attached to Hebei Medical University, Shijiazhuang, China, No. 12 Health Road, Shijiazhuang, 050011, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号